Department of Physiology and Pathophysiology, Fudan University School of Basic Medical Sciences, 130 Dong'an Rd., 207 Seventh Building, West Campus, Shanghai, 200032, China.
J Neuroimmune Pharmacol. 2024 Apr 13;19(1):13. doi: 10.1007/s11481-024-10116-y.
The occurrence of major asthma symptoms is largely attributed to airway vagal hypertonia, of which the central mechanisms remain unclear. This study tests the hypotheses that endothelin-1-mediated brainstem glial activation produces asthmatic airway vagal hypertonia via enhanced action of adenosine 5'-triphosphate on neuronal purinergic P2X4 receptors. A rat model of asthma was prepared using ovalbumin. Airway vagal tone was evaluated by the recurrent laryngeal discharge and plethysmographic measurement of pulmonary function. The changes in the brainstem were examined using ELISA, Western blot, luciferin-luciferase, quantitative reverse transcription-polymerase chain reaction, enzyme activity assay and immunofluorescent staining, respectively. The results showed that in the medulla of rats, endothelin receptor type B and P2X4 receptors were primarily expressed in astrocytes and neurons, respectively, and both of which, along with endothelin-1 content, were significantly increased after ovalbumin sensitization. Ovalbumin sensitization significantly increased recurrent laryngeal discharge, which was blocked by acute intracisternal injection of P2X4 receptor antagonist 5-BDBD, knockdown of brainstem P2X4 receptors, and chronic intraperitoneal injection of endothelin receptor type B antagonist BQ788, respectively. Ovalbumin sensitization activated microglia and astrocytes and significantly decreased ecto-5'-nucleotidase activity in the medulla, and all of which, together with the increase of medullary P2X4 receptor expression and decrease of pulmonary function, were reversed by chronic BQ788 treatment. These results demonstrated that in rats, allergic airway challenge activates both microglia and astrocytes in the medulla via enhanced endothelin-1/endothelin receptor type B signaling, which subsequently causes airway vagal hypertonia via augmented adenosine 5'-triphosphate/P2X4 receptor signaling in central neurons of airway vagal reflex.
主要哮喘症状的发生在很大程度上归因于气道迷走神经张力过高,其中心机制尚不清楚。本研究检验了以下假设:内皮素-1 介导的脑干胶质细胞激活通过增强神经元嘌呤能 P2X4 受体对三磷酸腺苷的作用产生哮喘气道迷走神经张力过高。使用卵清蛋白制备哮喘大鼠模型。通过喉返神经放电和肺功能体描法评估气道迷走神经张力。通过 ELISA、Western blot、荧光素-荧光素酶、定量逆转录聚合酶链反应、酶活性测定和免疫荧光染色分别检测脑干的变化。结果表明,在大鼠延髓中,内皮素受体 B 型和 P2X4 受体主要在星形胶质细胞和神经元中表达,两者以及内皮素-1 含量在卵清蛋白致敏后均显著增加。卵清蛋白致敏明显增加喉返神经放电,而急性脑室内注射 P2X4 受体拮抗剂 5-BDBD、敲低脑干 P2X4 受体和慢性腹腔内注射内皮素受体 B 拮抗剂 BQ788 均可阻断。卵清蛋白致敏激活小胶质细胞和星形胶质细胞,显著降低延髓中的外核苷酸酶 5'-活性,所有这些,连同髓质 P2X4 受体表达的增加和肺功能的降低,均可通过慢性 BQ788 治疗逆转。这些结果表明,在大鼠中,变应原性气道挑战通过增强内皮素-1/内皮素受体 B 信号转导激活延髓中的小胶质细胞和星形胶质细胞,随后通过增强气道迷走神经反射中枢神经元中的三磷酸腺苷/P2X4 受体信号转导引起气道迷走神经张力过高。